Posts
April 12 2017
Catalyst Biosciences Inc. announced the closing of their Underwritten offering in the amount of $18,939,000. EG&S acted as counsel to the Underwriter.
April 10 2017
SGOCO Group Ltd. announced the closing of their Registered Direct offering in the amount of $1,000,000. EG&S acted as counsel to the Investor.
April 06 2017
EKSO Bionics Holdings, Inc. announced the closing of their Registered Direct offering in the amount of $11,719,597. EG&S acted as counsel to the Placement Agent.
April 04 2017
ITUS Corporation announced the closing of its rights offering of common shares in the amount of $4,700,000. EG&S acted as counsel to ITUS.
April 03 2017
Atossa Genetics Inc. announced the closing of their Underwritten offering in the amount of $4,397,500. EG&S acted as counsel to the Underwriter.
April 03 2017
Dynatronics Corporation announced the closing of their PIPE in the amount of $9,000,000. EG&S acted as counsel to the Placement Agent.
March 31 2017
Douglas S. Ellenoff, a member of the Firm, wrote an article for LexisNexis; Lexis Practice Advisor titled “Market Trends: Crowdfunding.”
Click here to read the article
March 31 2017
Biocept Inc. announced the closing of their Registered Direct offering in the amount of $9,296,672. EG&S acted as counsel to the lead Investor.